Let’s Talk About the Benefits of an IL-17A Inhibitor

Please see the full Prescribing Information, bit.ly/3wjyveb including Medication Guide bit.ly/46Q8Jea.
Dermatologists share their preferred treatment approach.
Speakers in this video were not paid for their participation. However, as indicated, several of these individuals have consulted on other work for Novartis.
Learn more about COSENTYX (secukinumab) at www.cosentyxhc.... Be sure to subscribe for regular updates to our channel!
10/24 FA-11252100